Related Experiment Video
Updated: Mar 7, 2026

Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing
Elizabeth A Ferrick-Kiddie1, Joshua J C Rosenthal2,3, Gregory D Ayers4
1Department of Molecular Physiology &Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, United States.
Episodic Ataxia Type-1 (EA1) mutations in Kv1.1 potassium channels disrupt RNA editing. This RNA editing alteration, alongside direct mutation effects, may influence EA1 symptoms and channel function.
Area of Science:
- Molecular Biology
- Neurogenetics
- Ion Channel Physiology
Background:
- Adenosine-to-inosine (A-to-I) RNA editing is a crucial post-transcriptional modification.
- Voltage-gated potassium channels, like Kv1.1, are vital for neuronal function.
- Mutations in Kv1.1 are linked to Episodic Ataxia Type-1 (EA1), a neurological disorder.
Purpose of the Study:
- To investigate the impact of EA1-associated Kv1.1 mutations on RNA editing.
- To determine if altered RNA editing contributes to EA1 pathogenesis.
Main Methods:
- In vitro RNA editing assays.
- In vivo studies using a mouse model with a V408A Kv1.1 allele.
- Analysis of channel biophysical properties.
Main Results:
- Three EA1 mutations (V404I, I407M, V408A) within the RNA editing duplex significantly reduced RNA editing efficiency.
- Mutations impaired channel biophysical properties, including opening, closing, and inactivation.
- Altered RNA editing was observed in both in vitro and in vivo models.
Conclusions:
- EA1 mutations can disrupt the cis-regulatory elements required for Kv1.1 RNA editing.
- Altered RNA editing represents a novel mechanism contributing to EA1 symptoms, independent of direct mutation effects on channel function.
- This study highlights the role of RNA editing modulation in human genetic disorders.
Related Concept Videos
RNA Editing
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Leaky Scanning
Point and Frameshift Mutations

